Abstract
Aim
Urotensin II (UII), a pluripotent vasoactive peptide, plays a crucial role in development of insulin resistance. Gestational diabetes mellitus (GDM) is a metabolic disorder associated with insulin resistance. The aims of the current study were to compare UII levels in women with or without GDM and to investigate the relationship between UII and insulin resistance in women with GDM.
Methods
A total of 84 women were recruited in this case-control study (42 women with GDM and 42 age- and body mass index (BMI)-matched pregnant women without GDM as controls). GDM was diagnosed by a 2-h 75-g oral glucose tolerance test over a period of 24–28 gestational weeks. Circulating UII levels were assessed via the ELISA method. The metabolic parameters of the recruited women were also determined.
Results
The circulating levels of UII in women with GDM were higher than in controls (11.56 ± 4.13 vs. 7.62 ± 3.45 ng/ml, P < 0.001). UII showed a positive correlation with insulin resistance marker (HOMA-IR), fasting blood glucose, and BMI. Moreover, according to the results of multiple linear regression analyses, UII was independently related to HOMA-IR. Additionally, the binary logistic analysis revealed that the women with the highest tertile of UII levels showed increased risk for GDM by comparison with those women with the lowest tertile of UII levels.
Conclusion
Elevated UII levels are associated with insulin resistance in women with GDM.
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- CI:
-
Confidence interval
- CV:
-
Coefficient of variability
- DBP:
-
Diastolic blood pressure
- FBG:
-
Fasting blood glucose
- HDL-C:
-
High-density lipoprotein cholesterol
- HOMA-IR:
-
Homeostasis model assessment of insulin resistance
- hs-CRP:
-
High-sensitivity C-reactive protein
- GDM:
-
Gestational diabetes mellitus
- LDL-C:
-
Low-density lipoprotein cholesterol
- OGTT:
-
Oral glucose tolerance test
- OR:
-
Odds ratio
- SBP:
-
Systolic blood pressure
- T2DM:
-
Type 2 diabetes mellitus
- UII:
-
Urotensin II
- VIF:
-
Variance inflation factor
References
Fadl HE, Ostlund IKM, Magnuson AFK, Hanson USB (2010) Maternal and neonatal outcomes and time trends of gestational diabetes mellitus in Sweden from 1991 to 2003. Diabet Med 27:436–441
Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, Hod M, Kitzmiller JL, Kjos SL, Oats JN, Pettitt DJ, Sacks DA, Zoupas C (2007) Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 30(Suppl 2):S251–S260
Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25:1862–1868
Desoye G, Hauguel-de Mouzon S (2007) The human placenta in gestational diabetes mellitus: the insulin and cytokine network. Diabetes Care 30:S120–S126
Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier J-C, Huston-Presley L, Friedman JE, Kalhan SC, Catalano PM (2002) TNF- is a predictor of insulin resistance in human pregnancy. Diabetes 51:2207–2213
Tumurbaatar B, Poole AT, Olson G, Makhlouf M, Sallam HS, Thukuntla S, Kankanala S, Ekhaese O, Gomez G, Chandalia M, Abate N (2017) Adipose tissue insulin resistance in gestational diabetes. Metab Syndr Relat Disord 15:86–92
Friedman JE, Ishizuka T, Shao J, Huston L, Highman T, Catalano P (1999) Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes 48:1807–1814
Gruson D, Rousseau MF, Ketelslegers J-M, Hermans MP (2010) Raised plasma urotensin II in type 2 diabetes patients is associated with the metabolic syndrome phenotype. J Clin Hypertens (Greenwich) 12:653–660
Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AM, Louden CS, Foley JJ, Sauermelch CF, Coatney RW, Ao Z, Disa J, Holmes SD, Stadel JM, Martin JD, Liu WS, Glover GI, Wilson S, McNulty DE, Ellis CE, Elshourbagy NA, Shabon U, Trill JJ, Hay DW, Ohlstein EH, Bergsma DJ, Douglas SA (1999) Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401:282–286
Li Y, Zhao S, Wang Y, Chen Y, Lin Y, Zhu N, Zheng H, Wu M, Cheng D, Li Y, Bai L, Fan J, Liu E (2014) Urotensin II promotes atherosclerosis in cholesterol-fed rabbits. PLoS One 9:e95089
Li Y-Y, Shi Z-M, Yu X-Y, Feng P, Wang X-J (2016) Urotensin II-induced insulin resistance is mediated by NADPH oxidase-derived reactive oxygen species in HepG2 cells. World J Gastroenterol 22:5769
Matsushita M, Shichiri M, Imai T, Iwashina M, Tanaka H, Takasu N, Hirata Y (2001) Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. J Hypertens 19:2185–2190
Vaudry H, Do Rego J-C, Le Mevel J-C, Chatenet D, Tostivint H, Fournier A, Tonon M-C, Pelletier G, Conlon JM, Leprince J (2010) Urotensin II, from fish to human. Ann N Y Acad Sci 1200:53–66
Yilmaz Ö, Calan O, Kume T, Calan M (2013) The relationship of urotensin II with insulin resistance and hs-CRP in patients having PCOS. Gynecol Endocrinol 29:970–973
Totsune K, Takahashi K, Arihara Z, Sone M, Ito S, Murakami O (2003) Increased plasma urotensin II levels in patients with diabetes mellitus. Clin Sci (Lond) 104:1–5
Cheung BMY, Leung R, Man YB, Wong LYF (2004) Plasma concentration of urotensin II is raised in hypertension. J Hypertens 22:1341–1344
International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, Dyer AR, de Leiva A, Hod M, Kitzmiler JL, Lowe LP, McIntyre HD, Oats JJN, Omori Y, Schmidt MI (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676–682
Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
Ryan EA, O’Sullivan MJ, Skyler JS (1985) Insulin action during pregnancy: studies with the euglycemic clamp technique. Diabetes 34:380–389
Shao J, Yamashita H, Qiao L, Draznin B, Friedman JE (2002) Phosphatidylinositol 3-kinase redistribution is associated with skeletal muscle insulin resistance in gestational diabetes mellitus. Diabetes 51:19–29
Fasshauer M, Blüher M, Stumvoll M (2014) Adipokines in gestational diabetes. Lancet Diabetes Endocrinol 2:488–499
Suguro T, Watanabe T, Ban Y, Kodate S, Misaki A, Hirano T, Miyazaki A, ADACHI M (2007) Increased human urotensin II levels are correlated with carotid atherosclerosis in essential hypertension. Am J Hypertens 20:211–217
Huristoglu M, Ekiz A, Mete F, Okuturlar Y, Kocoglu H, Dumanli G, Cakirca M, Anataca G, Kuru O, Dogan S, Pehlivan B, Tabak O, Yildirim G, Dogan H, Erismis B (2017) Plasma urotensin II concentration in gestational diabetes. Arch Clin Exp Med
Wenyi Z, Suzuki S, Hirai M, Hinokio Y, Tanizawa Y, Matsutani A, Satoh J, Oka Y (2003) Role of urotensin II gene in genetic susceptibility to type 2 diabetes mellitus in Japanese subjects. Diabetologia 46:972–976
Okumus S, Igci YZ, Taskin T, Oztuzcu S, Gurler B, Eslik Z, Gogebakan B, Coskun E, Erbagci I, Demiryurek S, Cengiz B, Demiryurek AT (2012) Association between Thr21Met and Ser89Asn polymorphisms of the urotensin-II (UTS2) gene, diabetes mellitus, and diabetic retinopathy. Curr Eye Res 37:921–929
Suzuki S, Wenyi Z, Hirai M, Hinokio Y, Suzuki C, Yamada T, Yoshizumi S, Suzuki M, Tanizawa Y, Matsutani A, Oka Y (2004) Genetic variations at urotensin II and urotensin II receptor genes and risk of type 2 diabetes mellitus in Japanese. Peptides 25:1803–1808
Abell S, De Courten B, Boyle J, Teede H (2015) Inflammatory and other biomarkers: role in pathophysiology and prediction of gestational diabetes mellitus. Int J Mol Sci 16:13442–13473
Watanabe T, Kanome T, Miyazaki A, Katagiri T (2006) Human urotensin II as a link between hypertension and coronary artery disease. Hypertens Res 29:375–387
Cadirci E, Halici Z, Yayla M, Toktay E, Bayir Y, Karakus E, Topcu A, Buyuk B, Albayrak A (2016) Blocking of urotensin receptors as new target for treatment of carrageenan induced inflammation in rats. Peptides 82:35–43
Albertin G, Guidolin D, Sorato E, Oselladore B, Tortorella C, Ribatti D (2011) Urotensin-II-stimulated expression of pro-angiogenic factors in human vascular endothelial cells. Regul Pept 172:16–22
Sheridan MA, Plisetskaya EM, Bern HA, Gorbman A (1987) Effects of somatostatin-25 and urotensin II on lipid and carbohydrate metabolism of coho salmon, Oncorhynchus kisutch. Gen Comp Endocrinol 66:405–414
Kiss RS, You Z, Genest J, Behm DJ, Giaid A (2011) Urotensin II differentially regulates macrophage and hepatic cholesterol homeostasis. Peptides 32:956–963
Author information
Authors and Affiliations
Contributions
M.C., T.A., T.K., and F.B. participated in the study design and T.K. and M.C. performed ELISA. M.C., T.A., T.K., and F.B. participated in the study design, analyzed the data, and wrote, reviewed, and edited the manuscript. M.C., F.B., and T.A. provided serum samples and contributed to discussions of data interpretation. All authors reviewed and edited the manuscript. M.C. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Corresponding author
Ethics declarations
The subjects gave their oral and written informed consent before their inclusion in the study. The study adhered strictly to the principles of the Declaration of Helsinki as revised in 2008.
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Calan, M., Arkan, T., Kume, T. et al. The relationship between urotensin II and insulin resistance in women with gestational diabetes mellitus. Hormones 18, 91–97 (2019). https://doi.org/10.1007/s42000-018-0084-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42000-018-0084-7